市場調査レポート

商品コード

1396938

冠動脈バイパスグラフト装置市場：技術別、製品別、エンドユーザー別：世界の機会分析と産業予測、2023年～2032年

Coronary Artery Bypass Grafts Device Market By Technology, By Product, By End Users : Global Opportunity Analysis and Industry Forecast, 2023-2032

出版日: 2023年10月31日 | 発行: Allied Market Research

| ページ情報: 英文 259 Pages | 納期: 2～3営業日

価格

PDF (Single User License)

USD 5,730 898,234円

レポートPDFを1つのPCでご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回だけ可能です。印刷したレポートの利用もPDFのライセンス保持者になります。回覧のための複製も原則NGです。

PDF (5-user License)

USD 6,450 1,011,102円

レポートPDFを5名でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回可能です。印刷したレポートの利用もPDFのライセンス保持者5名となります。

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

USD 9,600 1,504,896円

レポートPDFとExcel定量データをひとつの企業、及びその子会社でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFとExcelの保存、表示、利用が可能です。PDFとExcel内のテキスト等のコピー＆ペーストは可能です。PDFとExcelの印刷回数の制限はありません。印刷したレポートの利用は企業、及びその子会社内にて共有可能です。無料でレポートのアップデートがご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

冠動脈バイパス移植術デバイス市場は、2022年に9億5,927万米ドルと評価され、2023年から2032年までのCAGRは3.7％を示し、2032年には13億8,230万米ドルに達すると予測されています。

冠動脈バイパス移植術デバイスの世界市場は、2022年に9億6,000万米ドルと評価され、2023年から2032年にかけて3.7%のCAGRで成長し、2032年には13億8,000万米ドルに達すると予測されています。

冠動脈バイパス移植術（CABG）デバイスは、冠動脈疾患の外科的治療において重要な役割を果たしています。冠動脈疾患は、心臓の筋肉に血液を供給する血管がプラークの蓄積によって狭くなったり詰まったりする疾患です。冠動脈バイパス術は、閉塞または狭窄した冠動脈を健康な血管でバイパスすることによって、心臓の筋肉に十分な血流を回復させるために行われる外科手術です。一般に、オンポンプとオフポンプはCABG手術の2つのタイプであり、オンポンプ冠動脈バイパス術では心肺バイパス回路と停止した心臓を使用して手術を行う点が異なります。一方、オフポンプ冠動脈バイパス移植術では、外科医は拍動している熱で手術を行う。

冠動脈バイパス移植術デバイス市場の成長を促進する主な要因は、彼らが冠動脈性心疾患（CHD）および動脈硬化などの関連疾患を開拓するリスクを持っているので、高齢者人口の増加であり、年齢とともに大幅に増加します。さらに、ライフスタイルの変化、座りっぱなしの習慣、不健康な食生活、ストレスレベルの上昇に起因する冠動脈性心疾患の有病率の急増も、市場の成長を促進すると予想されます。高齢になるにつれて、冠動脈疾患（CAD）や関連する心臓疾患を発症するリスクは大幅に増加します。冠動脈疾患は、冠動脈にプラークが蓄積し、心筋への血流が低下することを特徴とする、世界的に流行している疾患です。例えば、米国心臓協会の2023年の報告によると、最初の心臓発作の平均年齢は男性で65.6歳、女性で72.0歳と推定されています。

冠動脈バイパス移植術は、重度の冠動脈疾患の治療に用いられる重要な外科的介入です。冠動脈バイパス術は、閉塞または狭窄した冠動脈をバイパスするために、体の他の部分から健康な血管を移植することによって代替の血液経路を作り、心臓への適切な血流を回復させるものです。老年人口が冠動脈疾患や関連する心血管系疾患に罹患しやすくなっているため、冠動脈バイパス移植術や関連機器の需要が急増しています。さらに、高齢者は複数の併存疾患を抱えていることが多く、侵襲的で複雑な手術に比べ、冠動脈バイパス移植手術の理想的な候補者となっています。結論として、冠動脈疾患への罹患率が高い高齢者人口の増加は、冠動脈バイパスグラフト市場成長の極めて重要な原動力となっています。

市場の定義と範囲
主な調査結果
- 影響要因
- 主な投資機会
ポーターのファイブフォース分析
市場力学
- 促進要因
  - 心血管疾患の急増。
  - 不健康な食生活と現代の座りがちなライフスタイル。
  - 老人人口の増加。
- 抑制要因
  - 冠動脈バイパス移植術デバイスの高コスト。
- 機会
  - 心臓の健康に対する意識の高まり。

第4章冠動脈バイパス移植術デバイス市場：技術別

概要
オフポンプCABG
オンポンプCABG
低侵襲CABG

第5章冠動脈バイパス移植術デバイス市場：製品別

概要
人工心肺装置
内視鏡的血管採取システム
心臓ポジショナー
組織安定装置
その他

第6章冠動脈バイパス移植術デバイス市場：エンドユーザー別

概要
病院
心臓センター
その他

第7章冠動脈バイパス移植術デバイス市場：地域別

概要
北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- その他
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- 韓国
- その他
ラテンアメリカ
- ラテンアメリカ
- 中東・アフリカ

第8章競合情勢

イントロダクション
主要成功戦略
主要10社の製品マッピング
競合ダッシュボード
競合ヒートマップ
主要企業のポジショニング、2022年

第9章企業プロファイル

Medtronic
Baxter International Inc.
Terumo Corporation
Peters Surgical Group
Getinge AB
Genesee Biomedical Inc
Transonic Systems Inc.
Livanova, Plc
Condor MedTec GmbH
Saphena Medical, Inc.

図表

LIST OF TABLES

TABLE 01. GLOBAL CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 02. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR OFF PUMP CABG, BY REGION, 2022-2032 ($MILLION)
TABLE 03. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR ON PUMP CABG, BY REGION, 2022-2032 ($MILLION)
TABLE 04. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR MINIMALLY INVASIVE CABG, BY REGION, 2022-2032 ($MILLION)
TABLE 05. GLOBAL CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 06. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR CARDIOPULMONARY BYPASS MACHINES, BY REGION, 2022-2032 ($MILLION)
TABLE 07. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR ENDOSCOPIC VESSEL HARVESTING SYSTEMS, BY REGION, 2022-2032 ($MILLION)
TABLE 08. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR HEART POSITIONERS, BY REGION, 2022-2032 ($MILLION)
TABLE 09. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR TISSUE STABILIZER, BY REGION, 2022-2032 ($MILLION)
TABLE 10. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 11. GLOBAL CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 12. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
TABLE 13. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR CARDIAC CENTERS, BY REGION, 2022-2032 ($MILLION)
TABLE 14. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 15. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 16. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 17. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 18. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 19. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 20. U.S. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 21. U.S. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 22. U.S. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 23. CANADA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 24. CANADA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 25. CANADA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 26. MEXICO CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 27. MEXICO CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 28. MEXICO CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 29. EUROPE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 30. EUROPE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 31. EUROPE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 32. EUROPE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 33. GERMANY CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 34. GERMANY CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 35. GERMANY CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 36. FRANCE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 37. FRANCE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 38. FRANCE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 39. UK CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 40. UK CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 41. UK CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 42. ITALY CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 43. ITALY CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 44. ITALY CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 45. SPAIN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 46. SPAIN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 47. SPAIN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 48. REST OF EUROPE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 49. REST OF EUROPE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 50. REST OF EUROPE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 51. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 52. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 53. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 54. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 55. JAPAN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 56. JAPAN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 57. JAPAN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 58. CHINA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 59. CHINA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 60. CHINA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 61. INDIA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 62. INDIA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 63. INDIA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 64. AUSTRALIA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 65. AUSTRALIA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 66. AUSTRALIA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 67. SOUTH KOREA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 68. SOUTH KOREA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 69. SOUTH KOREA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 73. LAMEA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 74. LAMEA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 75. LAMEA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 76. LAMEA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 77. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 78. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 79. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 80. MIDDLE EAST AND AFRICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 81. MIDDLE EAST AND AFRICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 82. MIDDLE EAST AND AFRICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 83. MEDTRONIC: KEY EXECUTIVES
TABLE 84. MEDTRONIC: COMPANY SNAPSHOT
TABLE 85. MEDTRONIC: PRODUCT SEGMENTS
TABLE 86. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 87. BAXTER INTERNATIONAL INC.: KEY EXECUTIVES
TABLE 88. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
TABLE 89. BAXTER INTERNATIONAL INC.: PRODUCT SEGMENTS
TABLE 90. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO
TABLE 91. TERUMO CORPORATION: KEY EXECUTIVES
TABLE 92. TERUMO CORPORATION: COMPANY SNAPSHOT
TABLE 93. TERUMO CORPORATION: PRODUCT SEGMENTS
TABLE 94. TERUMO CORPORATION: PRODUCT PORTFOLIO
TABLE 95. PETERS SURGICAL GROUP: KEY EXECUTIVES
TABLE 96. PETERS SURGICAL GROUP: COMPANY SNAPSHOT
TABLE 97. PETERS SURGICAL GROUP: PRODUCT SEGMENTS
TABLE 98. PETERS SURGICAL GROUP: PRODUCT PORTFOLIO
TABLE 99. GETINGE AB: KEY EXECUTIVES
TABLE 100. GETINGE AB: COMPANY SNAPSHOT
TABLE 101. GETINGE AB: PRODUCT SEGMENTS
TABLE 102. GETINGE AB: PRODUCT PORTFOLIO
TABLE 103. GENESEE BIOMEDICAL INC: KEY EXECUTIVES
TABLE 104. GENESEE BIOMEDICAL INC: COMPANY SNAPSHOT
TABLE 105. GENESEE BIOMEDICAL INC: PRODUCT SEGMENTS
TABLE 106. GENESEE BIOMEDICAL INC: PRODUCT PORTFOLIO
TABLE 107. TRANSONIC SYSTEMS INC.: KEY EXECUTIVES
TABLE 108. TRANSONIC SYSTEMS INC.: COMPANY SNAPSHOT
TABLE 109. TRANSONIC SYSTEMS INC.: PRODUCT SEGMENTS
TABLE 110. TRANSONIC SYSTEMS INC.: PRODUCT PORTFOLIO
TABLE 111. LIVANOVA, PLC: KEY EXECUTIVES
TABLE 112. LIVANOVA, PLC: COMPANY SNAPSHOT
TABLE 113. LIVANOVA, PLC: PRODUCT SEGMENTS
TABLE 114. LIVANOVA, PLC: PRODUCT PORTFOLIO
TABLE 115. LIVANOVA, PLC: KEY STRATERGIES
TABLE 116. CONDOR MEDTEC GMBH: KEY EXECUTIVES
TABLE 117. CONDOR MEDTEC GMBH: COMPANY SNAPSHOT
TABLE 118. CONDOR MEDTEC GMBH: PRODUCT SEGMENTS
TABLE 119. CONDOR MEDTEC GMBH: PRODUCT PORTFOLIO
TABLE 120. SAPHENA MEDICAL, INC.: KEY EXECUTIVES
TABLE 121. SAPHENA MEDICAL, INC.: COMPANY SNAPSHOT
TABLE 122. SAPHENA MEDICAL, INC.: PRODUCT SEGMENTS
TABLE 123. SAPHENA MEDICAL, INC.: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET,2022-2032
FIGURE 03. TOP IMPACTING FACTORS IN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET (2020 TO 2022)
FIGURE 04. TOP INVESTMENT POCKETS IN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET (2023-2032)
FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 06. LOW THREAT OF NEW ENTRANTS
FIGURE 07. LOW THREAT OF SUBSTITUTES
FIGURE 08. LOW INTENSITY OF RIVALRY
FIGURE 09. LOW BARGAINING POWER OF BUYERS
FIGURE 10. GLOBAL CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR OFF PUMP CABG, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR ON PUMP CABG, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR MINIMALLY INVASIVE CABG, BY COUNTRY 2022 AND 2032(%)
FIGURE 15. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022 AND 2032(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR CARDIOPULMONARY BYPASS MACHINES, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR ENDOSCOPIC VESSEL HARVESTING SYSTEMS, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR HEART POSITIONERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR TISSUE STABILIZER, BY COUNTRY 2022 AND 2032(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 21. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022 AND 2032(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR CARDIAC CENTERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 25. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET BY REGION, 2022 AND 2032(%)
FIGURE 26. U.S. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
FIGURE 27. CANADA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
FIGURE 28. MEXICO CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
FIGURE 29. GERMANY CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
FIGURE 30. FRANCE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
FIGURE 31. UK CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
FIGURE 32. ITALY CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
FIGURE 33. SPAIN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
FIGURE 34. REST OF EUROPE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
FIGURE 35. JAPAN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
FIGURE 36. CHINA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
FIGURE 37. INDIA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
FIGURE 38. AUSTRALIA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
FIGURE 39. SOUTH KOREA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
FIGURE 40. REST OF ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
FIGURE 41. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
FIGURE 42. MIDDLE EAST AND AFRICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)
FIGURE 43. TOP WINNING STRATEGIES, BY YEAR (2022-2023)
FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT (2022-2023)
FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY (2022-2023)
FIGURE 46. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 47. COMPETITIVE DASHBOARD
FIGURE 48. COMPETITIVE HEATMAP: CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET
FIGURE 49. TOP PLAYER POSITIONING, 2022
FIGURE 50. MEDTRONIC: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 51. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 52. MEDTRONIC: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 53. BAXTER INTERNATIONAL INC.: NET SALES, 2020-2022 ($MILLION)
FIGURE 54. BAXTER INTERNATIONAL INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 55. BAXTER INTERNATIONAL INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 56. TERUMO CORPORATION: NET SALES, 2021-2023 ($MILLION)
FIGURE 57. TERUMO CORPORATION: REVENUE SHARE BY SEGMENT, 2023 (%)
FIGURE 58. TERUMO CORPORATION: REVENUE SHARE BY REGION, 2023 (%)
FIGURE 59. GETINGE AB: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 60. GETINGE AB: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 61. GETINGE AB: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 62. LIVANOVA, PLC: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 63. LIVANOVA, PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 64. LIVANOVA, PLC: REVENUE SHARE BY REGION, 2022 (%)

Product Code: A197949

The coronary artery bypass grafts device market was valued at $959.27 million in 2022 and is estimated to reach $1,382.30 million by 2032, exhibiting a CAGR of 3.7% from 2023 to 2032. The global coronary artery bypass grafts device market was valued at $0.96 billion in 2022, and is projected to reach $1.38 billion by 2032, growing at a CAGR of 3.7% from 2023 to 2032.

Coronary artery bypass graft (CABG) device plays an important role in the surgical treatment of coronary artery disease. Coronary artery disease is a condition where the blood vessels supplying blood to the heart muscles become narrowed or blocked due to the buildup of plaque. Coronary artery bypass graft is a surgical procedure which is carried out to restore adequate blood flow to the heart muscles by bypassing the blocked or narrowed coronary arteries with healthy blood vessels. In general, on-pump and off-pump are the two types of CABG surgical procedures with the difference being the use of a cardiopulmonary bypass circuit and an arrested heart to operate during an on-pump coronary artery bypass graft. On the other hand, during off-pump coronary artery bypass graft, the surgeons operates on the beating heat.

The key factors driving the growth of the coronary artery bypass graft devices market are rise in geriatric population as they have the risk of developing coronary heart disease (CHD) and related conditions such as atherosclerosis increases significantly with age. Furthermore, surge in prevalence of coronary heart diseases owing to lifestyle changes, sedentary habits, unhealthy diets, and increase in stress levels is also expected to drive the growth of the market. As people age, their risk of developing coronary artery disease (CAD) and related cardiac issues significantly increases. Coronary artery disease is a prevalent condition worldwide, characterized by the accumulation of plaque in the coronary arteries, leading to reduced blood flow to the heart muscle. For instance, according to a 2023 report by American Heart Association, it was estimated that the average age at the first heart attack was 65.6 years for males and 72.0 years for females.

Coronary artery bypass grafting is a crucial surgical intervention used to treat severe coronary artery disease. It involves the creation of alternative blood pathways by grafting healthy blood vessels from other parts of the body to bypass the blocked or narrowed coronary arteries, thereby restoring proper blood flow to the heart. As the geriatric population is more prone to coronary artery disease and related cardiovascular problems, the demand for coronary artery bypass graft procedures and associated devices has surged. Furthermore, the elderly often have multiple comorbidities, making them ideal candidates for coronary artery bypass graft surgeries as compared to more invasive or complex procedures. In conclusion, the escalating geriatric population, with its higher susceptibility to coronary artery disease, has become a pivotal driver for the growth of the coronary artery bypass graft devices market.

In addition, surge in prevalence of coronary heart disease is expected to act as a significant driver for the coronary artery bypass graft devices market. The bypass restores the blood flow to the ischemic myocardium which, in turn, restores function, viability, and relieves anginal symptoms. The global burden of coronary heart disease has been on the rise, primarily attributed to lifestyle factors such as sedentary lifestyles, unhealthy diets, and increasing rates of obesity. For instance, according to a 2023 report by U.S. National library of medicine, it was estimated that globally almost 400,000 coronary artery bypass grafting surgeries are performed each year making it the most commonly performed major surgical procedure. Thus, the surge in the prevalence of coronary heart disease is expected to drive the growth of the coronary artery bypass graft devices market.

However, high cost of procedures might act as restraint for the coronary artery bypass graft devices market. The high cost of coronary artery bypass graft surgery makes it less accessible to individuals without adequate health insurance coverage. The cost of devices, hospital stays, and post-operative care be a significant financial burden for patients.

The coronary artery bypass graft devices market is segmented on the basis of technology, product, end user, and region. By technology, the market is categorized into off-pump, on-pump, and minimally invasive CABG. By product, the market is classified into cardiopulmonary bypass machines, endoscopic vessel harvesting systems, heart positioners, tissue stabilizer and others. By end user, the market is divided into hospitals, cardiac centers, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global coronary artery bypass graft devices market are Medtronic, Baxter International Inc, Terumo Corporation, Teleflex Incorporated, Peters Surgical Group, Getinge AB, Genesee Biomedical Inc, Transonic Systems Inc., Saphena Medical, Inc. and Condor MedTec GmbH.

Key Benefits for Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the coronary artery bypass grafts device market analysis from 2022 to 2032 to identify the prevailing coronary artery bypass grafts device market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the coronary artery bypass grafts device market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global coronary artery bypass grafts device market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Technology Trend Analysis
Patient/epidemiology data at country, region, global level
Regulatory Guidelines
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
SWOT Analysis

Key Market Segments

By End Users

Hospitals
Cardiac Centers
Others

By Technology

Off pump CABG
On pump CABG
Minimally invasive CABG

By Product

Endoscopic Vessel Harvesting Systems
Heart Positioners
Tissue Stabilizer
Others
Cardiopulmonary Bypass Machines

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Latin America
- Middle East And Africa

Key Market Players:

Terumo Corporation
Peters Surgical Group
Genesee Biomedical Inc
Transonic Systems Inc.
Condor MedTec GmbH
Baxter International Inc.
Getinge AB
Saphena Medical, Inc.
Medtronic
Livanova, Plc

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
- 3.3.1. Low bargaining power of suppliers
- 3.3.2. Low threat of new entrants
- 3.3.3. Low threat of substitutes
- 3.3.4. Low intensity of rivalry
- 3.3.5. Low bargaining power of buyers
3.4. Market dynamics
- 3.4.1. Drivers
  - 3.4.1.1. Surge in prevalence of cardiovascular diseases.
  - 3.4.1.2. Unhealthy diet and modern sedentary lifestyle.
  - 3.4.1.3. Rise in geriatric population.
- 3.4.2. Restraints
  - 3.4.2.1. High cost of coronary artery bypass graft devices.
- 3.4.3. Opportunities
  - 3.4.3.1. Rise in awareness about heart health

CHAPTER 4: CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Off pump CABG
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. On pump CABG
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
4.4. Minimally invasive CABG
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country

CHAPTER 5: CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Cardiopulmonary Bypass Machines
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Endoscopic Vessel Harvesting Systems
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
5.4. Heart Positioners
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
5.5. Tissue Stabilizer
- 5.5.1. Key market trends, growth factors and opportunities
- 5.5.2. Market size and forecast, by region
- 5.5.3. Market share analysis by country
5.6. Others
- 5.6.1. Key market trends, growth factors and opportunities
- 5.6.2. Market size and forecast, by region
- 5.6.3. Market share analysis by country

CHAPTER 6: CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS

6.1. Overview
- 6.1.1. Market size and forecast
6.2. Hospitals
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
6.3. Cardiac Centers
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
6.4. Others
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country

CHAPTER 7: CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY REGION

7.1. Overview
- 7.1.1. Market size and forecast By Region
7.2. North America
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by Technology
- 7.2.3. Market size and forecast, by Product
- 7.2.4. Market size and forecast, by End Users
- 7.2.5. Market size and forecast, by country
  - 7.2.5.1. U.S.
  - 7.2.5.1.1. Market size and forecast, by Technology
  - 7.2.5.1.2. Market size and forecast, by Product
  - 7.2.5.1.3. Market size and forecast, by End Users
  - 7.2.5.2. Canada
  - 7.2.5.2.1. Market size and forecast, by Technology
  - 7.2.5.2.2. Market size and forecast, by Product
  - 7.2.5.2.3. Market size and forecast, by End Users
  - 7.2.5.3. Mexico
  - 7.2.5.3.1. Market size and forecast, by Technology
  - 7.2.5.3.2. Market size and forecast, by Product
  - 7.2.5.3.3. Market size and forecast, by End Users
7.3. Europe
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by Technology
- 7.3.3. Market size and forecast, by Product
- 7.3.4. Market size and forecast, by End Users
- 7.3.5. Market size and forecast, by country
  - 7.3.5.1. Germany
  - 7.3.5.1.1. Market size and forecast, by Technology
  - 7.3.5.1.2. Market size and forecast, by Product
  - 7.3.5.1.3. Market size and forecast, by End Users
  - 7.3.5.2. France
  - 7.3.5.2.1. Market size and forecast, by Technology
  - 7.3.5.2.2. Market size and forecast, by Product
  - 7.3.5.2.3. Market size and forecast, by End Users
  - 7.3.5.3. UK
  - 7.3.5.3.1. Market size and forecast, by Technology
  - 7.3.5.3.2. Market size and forecast, by Product
  - 7.3.5.3.3. Market size and forecast, by End Users
  - 7.3.5.4. Italy
  - 7.3.5.4.1. Market size and forecast, by Technology
  - 7.3.5.4.2. Market size and forecast, by Product
  - 7.3.5.4.3. Market size and forecast, by End Users
  - 7.3.5.5. Spain
  - 7.3.5.5.1. Market size and forecast, by Technology
  - 7.3.5.5.2. Market size and forecast, by Product
  - 7.3.5.5.3. Market size and forecast, by End Users
  - 7.3.5.6. Rest of Europe
  - 7.3.5.6.1. Market size and forecast, by Technology
  - 7.3.5.6.2. Market size and forecast, by Product
  - 7.3.5.6.3. Market size and forecast, by End Users
7.4. Asia-Pacific
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by Technology
- 7.4.3. Market size and forecast, by Product
- 7.4.4. Market size and forecast, by End Users
- 7.4.5. Market size and forecast, by country
  - 7.4.5.1. Japan
  - 7.4.5.1.1. Market size and forecast, by Technology
  - 7.4.5.1.2. Market size and forecast, by Product
  - 7.4.5.1.3. Market size and forecast, by End Users
  - 7.4.5.2. China
  - 7.4.5.2.1. Market size and forecast, by Technology
  - 7.4.5.2.2. Market size and forecast, by Product
  - 7.4.5.2.3. Market size and forecast, by End Users
  - 7.4.5.3. India
  - 7.4.5.3.1. Market size and forecast, by Technology
  - 7.4.5.3.2. Market size and forecast, by Product
  - 7.4.5.3.3. Market size and forecast, by End Users
  - 7.4.5.4. Australia
  - 7.4.5.4.1. Market size and forecast, by Technology
  - 7.4.5.4.2. Market size and forecast, by Product
  - 7.4.5.4.3. Market size and forecast, by End Users
  - 7.4.5.5. South Korea
  - 7.4.5.5.1. Market size and forecast, by Technology
  - 7.4.5.5.2. Market size and forecast, by Product
  - 7.4.5.5.3. Market size and forecast, by End Users
  - 7.4.5.6. Rest of Asia-Pacific
  - 7.4.5.6.1. Market size and forecast, by Technology
  - 7.4.5.6.2. Market size and forecast, by Product
  - 7.4.5.6.3. Market size and forecast, by End Users
7.5. LAMEA
- 7.5.1. Key market trends, growth factors and opportunities
- 7.5.2. Market size and forecast, by Technology
- 7.5.3. Market size and forecast, by Product
- 7.5.4. Market size and forecast, by End Users
- 7.5.5. Market size and forecast, by country
  - 7.5.5.1. Latin America
  - 7.5.5.1.1. Market size and forecast, by Technology
  - 7.5.5.1.2. Market size and forecast, by Product
  - 7.5.5.1.3. Market size and forecast, by End Users
  - 7.5.5.2. Middle East And Africa
  - 7.5.5.2.1. Market size and forecast, by Technology
  - 7.5.5.2.2. Market size and forecast, by Product
  - 7.5.5.2.3. Market size and forecast, by End Users

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

9.1. Medtronic
- 9.1.1. Company overview
- 9.1.2. Key executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.1.6. Business performance
9.2. Baxter International Inc.
- 9.2.1. Company overview
- 9.2.2. Key executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
- 9.2.6. Business performance
9.3. Terumo Corporation
- 9.3.1. Company overview
- 9.3.2. Key executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
- 9.3.6. Business performance
9.4. Peters Surgical Group
- 9.4.1. Company overview
- 9.4.2. Key executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
9.5. Getinge AB
- 9.5.1. Company overview
- 9.5.2. Key executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
- 9.5.6. Business performance
9.6. Genesee Biomedical Inc
- 9.6.1. Company overview
- 9.6.2. Key executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
9.7. Transonic Systems Inc.
- 9.7.1. Company overview
- 9.7.2. Key executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
9.8. Livanova, Plc
- 9.8.1. Company overview
- 9.8.2. Key executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
- 9.8.6. Business performance
- 9.8.7. Key strategic moves and developments
9.9. Condor MedTec GmbH
- 9.9.1. Company overview
- 9.9.2. Key executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
9.10. Saphena Medical, Inc.
- 9.10.1. Company overview
- 9.10.2. Key executives
- 9.10.3. Company snapshot
- 9.10.4. Operating business segments
- 9.10.5. Product portfolio

冠動脈バイパスグラフト装置市場：技術別、製品別、エンドユーザー別：世界の機会分析と産業予測、2023年～2032年

Coronary Artery Bypass Grafts Device Market By Technology, By Product, By End Users : Global Opportunity Analysis and Industry Forecast, 2023-2032

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場概要

第4章冠動脈バイパス移植術デバイス市場：技術別

第5章冠動脈バイパス移植術デバイス市場：製品別

第6章冠動脈バイパス移植術デバイス市場：エンドユーザー別

第7章冠動脈バイパス移植術デバイス市場：地域別

第8章競合情勢

第9章企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Market Segments

By End Users

By Technology

By Product

By Region

Key Market Players:

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY

CHAPTER 5: CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT

CHAPTER 6: CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS

CHAPTER 7: CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY REGION

CHAPTER 8: COMPETITIVE LANDSCAPE

CHAPTER 9: COMPANY PROFILES

冠動脈バイパスグラフト装置市場：技術別、製品別、エンドユーザー別：世界の機会分析と産業予測、2023年～2032年

Coronary Artery Bypass Grafts Device Market By Technology, By Product, By End Users : Global Opportunity Analysis and Industry Forecast, 2023-2032

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

第4章 冠動脈バイパス移植術デバイス市場：技術別

第5章 冠動脈バイパス移植術デバイス市場：製品別

第6章 冠動脈バイパス移植術デバイス市場：エンドユーザー別

第7章 冠動脈バイパス移植術デバイス市場：地域別

第8章 競合情勢

第9章 企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Market Segments

By End Users

By Technology

By Product

By Region

Key Market Players:

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY

CHAPTER 5: CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT

CHAPTER 6: CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS

CHAPTER 7: CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY REGION

CHAPTER 8: COMPETITIVE LANDSCAPE

CHAPTER 9: COMPANY PROFILES

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場概要

第4章冠動脈バイパス移植術デバイス市場：技術別

第5章冠動脈バイパス移植術デバイス市場：製品別

第6章冠動脈バイパス移植術デバイス市場：エンドユーザー別

第7章冠動脈バイパス移植術デバイス市場：地域別

第8章競合情勢

第9章企業プロファイル